Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.

Ehrmann, D A, Sturis, J, Byrne, M M, Karrison, T, Rosenfield, R L, Polonsky, K S·1995·Journal of Clinical Investigation
DOI 10.1172/jci118064

Cited by (426)

Items 101–200 of 426

  1. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome
    Michael Heard, Anita Pierce, Sandra Ann Carson, John E. Buster · 2002 · Fertility and Sterility
  2. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome
    Kürşad Ünlühızarcı, Fahrettin Keleştimur, Fahrı Bayram, Yılmaz Şahin, Ahmet Tutuş · 1999 · Clinical Endocrinology
  3. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome
    Pernille Fog Svendsen, Lisbeth Nilas, Kirsten Nørgaard, Jens‐Erik Beck Jensen, Sten Madsbad · 2008 · Human Reproduction
  4. Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review
    Sarantis Livadas, Panagiotis G. Anagnostis, Julia Κ. Bosdou, Dimitra Bantouna, Rodis D. Paparodis · 2022 · World Journal of Diabetes
  5. Relationship of Insulin Receptor Substrate-1 and -2 Genotypes to Phenotypic Features of Polycystic Ovary Syndrome
    David A. Ehrmann, Xu Anna Tang, Issei Yoshiuchi, Nancy Jean Cox, Graeme I. Bell · 2002 · The Journal of Clinical Endocrinology & Metabolism
  6. The Relationship between C-Reactive Protein and Carotid Intima-Media Wall Thickness in Middle-Aged Women with Polycystic Ovary Syndrome
    Evelyn O. Talbott, Jeanne V. Zborowski, M. Y. Boudreaux, Kathleen P. McHugh-Pemu, K. Sutton-Tyrrell, David S. Guzick · 2004 · The Journal of Clinical Endocrinology & Metabolism
  7. β-Cell Function: A Key Pathological Determinant in Polycystic Ovary Syndrome
    Mark O. Goodarzi, Stephen W. Erickson, Sidney C. Port, Robert I. Jennrich, Stanley G. Korenman · 2005 · The Journal of Clinical Endocrinology & Metabolism
  8. Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome
    Teresa Sir‐Petermann, Bárbara Angel B, Manuel Alejandro Maliqueo, F. Carvajal, José Luis Santos, F. Pérez-Bravo · 2002 · Diabetologia
  9. Polycystic Ovary Syndrome in Adolescence
    Blank, Susan K., Helm, Kristin D., McCartney, Christopher R., Marshall, John C. · 2008 · Annals of the New York Academy of Sciences
  10. Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer
    Dah‐Ching Ding, Weishan Chen, J.-H. Wang, Shinn‐Zong Lin · 2018 · Medicine
  11. Genetics of Polycystic Ovary Syndrome
    Thomas M. Barber, Stephen Franks · 2012 · Frontiers of hormone research
  12. Effects of probiotic supplementation on pancreatic β-cell function and c-reactive protein in women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial
    Gholamreza Askari, Tanaz Shoaei, Motahar Heidari‐Beni, Hatav Ghasemi Tehrani, Awat Feizi, Ahmad Esmaillzadeh · 2015 · International Journal of Preventive Medicine
  13. MENSTRUAL DISORDERS IN ADOLESCENTS
    Gordon, Catherine M. · 1999 · Pediatric Clinics of North America
  14. Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses.
    K. Utzschneider, R. Prigeon, D. Carr, R. Hull, J. Tong, J. Shofer, B. Retzlaff, R. Knopp, S. Kahn · 2006 · Diabetes Care
  15. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?
    Fauzia Haq Nawaz, Roha Khalid, Tahira Yasmeen Naru, Javed Rizvi · 2008 · Journal of obstetrics and gynaecology research
  16. Polycystic ovary syndrome in adolescents
    Stephanie S. Rothenberg, R. M. Beverley, Emily Barnard, Massoud Baradaran-Shoraka, Joseph S. Sanfilippo · 2017 · Best Practice & Research Clinical Obstetrics & Gynaecology
  17. Identification of a Functional Polymorphism of the Human Type 5 17β-Hydroxysteroid Dehydrogenase Gene Associated with Polycystic Ovary Syndrome
    Kenan Qin, David A. Ehrmann, Nancy Jean Cox, Samuel Refetoff, Robert L. Rosenfield · 2006 · The Journal of Clinical Endocrinology & Metabolism
  18. Assessment of insulin secretion in relation to insulin resistance
    Andrea Mari, Bo Åhrén, Giovanni Pacini · 2005 · Current Opinion in Clinical Nutrition & Metabolic Care
  19. Insulin Resistance and Impaired Insulin Secretion in Prenatally Androgenized Male Rhesus Monkeys
    Cristin M. Bruns, Scott T. Baum, Ricki J. Colman, Joel Robert Eisner, Joseph W. Kemnitz, Richard H. Weindruch, David Howard Abbott · 2004 · The Journal of Clinical Endocrinology & Metabolism
  20. Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome
    Merz, C. Noel Bairey, Shaw, Leslee J., Azziz, Ricardo, Stanczyk, Frank Z., Sopko, George, Braunstein, Glenn D., Kelsey, Sheryl F., Kip, Kevin E., Cooper-DeHoff, Rhonda M., Johnson, B. Delia et al. · 2016 · Journal of Women's Health
  21. Review of methods for measuring β‐cell function: D esign considerations from the R estoring I nsulin S ecretion ( RISE ) C onsortium
    Tamara S. Hannon, Steven E. Kahn, Kristina M. Utzschneider, Thomas A. Buchanan, Kristen J. Nadeau, Philip Scott Zeitler, David A. Ehrmann, Silva A Arslanian, Sonia Caprio, Sharon L. Edelstein et al. · 2017 · Diabetes Obesity and Metabolism
  22. Cardiometabolic features of polycystic ovary syndrome
    Leslie Hoffman, David A. Ehrmann · 2008 · Nature Clinical Practice Endocrinology & Metabolism
  23. Islet adaptation to insulin resistance: mechanisms and implications for intervention
    Bo Åhrén, Giovanni Pacini · 2004 · Diabetes Obesity and Metabolism
  24. Reduced Serum Glycodelin and Insulin-Like Growth Factor-Binding Protein-1 in Women with Polycystic Ovary Syndrome during First Trimester of Pregnancy
    Daniela J. Jakubowicz, Paulina A. Essah, Markku T. Seppälä, Salomón Jakubowicz, Jean‐Patrice Baillargeon, Riitta A. Koistinen, John E. Nestler · 2004 · The Journal of Clinical Endocrinology & Metabolism
  25. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome
    LiWei Cho, Eric S. Kilpatrick, Brian George Keevil, Anne‐Marie Coady, Stephen Lawrence Atkin · 2008 · Clinical Endocrinology
  26. POLYCYSTIC OVARY SYNDROME
    Ann E. Taylor · 1998 · Endocrinology and Metabolism Clinics of North America
  27. Insulin Sensitivity and β-Cell Function in Women With Polycystic Ovary Syndrome
    Jana Vrbíková, Běla Bendlová, Martin Hill, Markéta Vaňková, K Vondra, Luboslav Stárka · 2002 · Diabetes Care
  28. The Effects of Probiotics or Synbiotics Supplementation in Women with Polycystic Ovarian Syndrome: a Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Javad Heshmati, Farnaz Farsi, Somaye Yosaee, Maryam Razavi, Mahroo Rezaeinejad, Elham Karimie, Mahdi Sepidarkish · 2018 · Probiotics and Antimicrobial Proteins
  29. Prevalence of gestational diabetes mellitus and associated factors among women attending antenatal care at Gondar town public health facilities, Northwest Ethiopia
    Achenef Asmamaw Muche, Oladapo O. Olayemi, Yigzaw Kebede Gete · 2019 · BMC Pregnancy and Childbirth
  30. Ovarian Hypertension: Polycystic Ovary Syndrome
    Rhonda Bentley–Lewis, Ellen W. Seely, Andrea Elizabeth Dunaif · 2011 · Endocrinology and Metabolism Clinics of North America
  31. Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
    Robert L. Rosenfield · 2001 · Journal of the American Academy of Dermatology
  32. Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity
    Larsson, H., Ahrén, B. · 1999 · Diabetologia
  33. Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes.
    Hollingdal, M, Juhl, C B, Pincus, S M, Sturis, J, Veldhuis, J D, Polonsky, K S, Pørksen, N, Schmitz, O · 2000 · Diabetes
  34. State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS)
    David H. Geller, Danièle Pacaud, Catherine M. Gordon, Madhusmita Misra · 2011 · International Journal of Pediatric Endocrinology
  35. Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements
    Poli Mara Spritzer · 2001 · Human Reproduction
  36. Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis: Metformin vs thiazolidinediones for PCOS
    Li, X-J., Yu, Y-X., Liu, C-Q., Zhang, W., Zhang, H-J., Yan, B., Wang, L-Y., Yang, S-Y., Zhang, S-H. · 2011 · Clinical Endocrinology
  37. Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin Resistance
    Danalea V. Skarra, Angelina M. Hernandez, Alissa J. Rivera, Arya R. Anvar, Varykina G. Thackray · 2017 · Endocrinology
  38. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
    Tomlinson, J., Millward, A., Stenhouse, E., Pinkney, J. · 2010 · Diabetic Medicine
  39. Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
    Torchen, Laura C. · 2017 · Current Diabetes Reports
  40. 6 Current concepts of polycystic ovary syndrome
    Robert L. Rosenfield · 1997 · Baillière s Clinical Obstetrics and Gynaecology
  41. The β Cell in Diabetes: Integrating Biomarkers With Functional Measures
    Steven E. Kahn, Yi‐Chun Chen, Nathalie Esser, Austin J. Taylor, Daniël H. van Raalte, Sakeneh Zraika, C. Bruce Verchere · 2021 · Endocrine Reviews
  42. Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study
    Tao Tao, Yi Zhang, Yuchen Zhu, Jia-Rong Fu, Yuying Wang, Jie Cai, Jingyu Ma, Yu Xu, Yining Gao, Yun Wei Sun et al. · 2020 · The Journal of Clinical Endocrinology & Metabolism
  43. Treatment of PCOS in adolescence
    Julia Warren-Ulanch, Silva A Arslanian · 2006 · Best Practice & Research Clinical Endocrinology & Metabolism
  44. The role of vitamin D in polycystic ovary syndrome
    Meng‐Hsing Wu, Ming‐Wei Lin · 2015 · The Indian Journal of Medical Research
  45. Coronary artery disease risk in young women with polycystic ovary syndrome
    Dah‐Ching Ding, I‐Ju Tsai, Jen‐Hung Wang, Shinn‐Zong Lin, Fung‐Chang Sung · 2018 · Oncotarget
  46. Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance
    Helena Elding Larsson, Bo Ahr�n · 1996 · Diabetologia
  47. An examination of β‐cell function measures and their potential use for estimating β‐cell mass
    Steven E. Kahn, D. B. Carr, Mirjam V. Faulenbach, Kristina M. Utzschneider · 2008 · Diabetes Obesity and Metabolism
  48. Insulin resistance in patients with polycystic ovary syndrome
    Annika K. Schröder, S. Tauchert, Olaf Ortmann, Klaus Diedrich, Jürgen Michael Weiss · 2004 · Annals of Medicine
  49. Effects of protein versus simple sugar intake on weight loss in polycystic ovary syndrome (according to the National Institutes of Health criteria)
    Kasim-Karakas, Sidika E., Almario, Rogelio U., Cunningham, Wendy · 2009 · Fertility and Sterility
  50. Insulin resistance/hyperinsulinemia and reproductive disorders in infertile women
    Tetsurou Sakumoto, Yoshimitu Tokunaga, Hideaki Tanaka, Makoto Nohara, 絵美 茂木, Tadahiko Shinkawa, Aritoshi Nakaza, Masahiro Higashi · 2010 · Reproductive Medicine and Biology
  51. Increased androgen levels in rats impair glucose-stimulated insulin secretion through disruption of pancreatic beta cell mitochondrial function
    Hongdong Wang, Xiaping Wang, Yunxia Zhu, Fang Chen, Yujie Sun, Xiao Han · 2015 · The Journal of Steroid Biochemistry and Molecular Biology
  52. DECREASES IN OVARIAN CYTOCHROME P450c17 a ACTIVITY AND SERUM FREE TESTOSTERONE AFTER REDUCTION OF INSULIN SECRETION IN POLYCYSTIC OVARY SYNDROME
    J Ohn E. N Estler, Aniela J. J Akubowicz · 2011
  53. Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome
    Matthijs L. Hendriks, Johannes C. F. Ket, Peter G.A. Hompes, Roy Homburg, Cornelis Bavo Lambalk · 2007 · Human Reproduction Update
  54. Diagnostic Criteria for Polycystic Ovarian Syndrome
    Frank J. Broekmans, Bart C.J.M. Fauser · 2006 · Endocrine
  55. The Pancreas Is Altered by In Utero Androgen Exposure: Implications for Clinical Conditions Such as Polycystic Ovary Syndrome (PCOS)
    Mick T. Rae, Cathal Grace, Kirsten Hogg, Lisa Marie Wilson, Sophie L. McHaffie, Seshadri Ramaswamy, Janis MacCallum, Fiona Connolly, Alan S. McNeilly, Colin Duncan · 2013 · PLoS ONE
  56. Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome--a long term follow-up
    Miriam Hudecova, Jan Holte, Matts Olovsson, Anders Olof Larsson, Christian Berne, Inger Sundström Poromaa · 2011 · Human Reproduction
  57. Diabetes Prevalence and Risk Factors in Polycystic Ovary Syndrome
    Richard S. Legro · 2001 · Obstetrics and Gynecology Clinics of North America
  58. Prevalence of Polycystic Ovary Syndrome in Patients With Pediatric Type 2 Diabetes
    Milena Cioana, Jiawen Deng, Ajantha Nadarajah, Maggie Hou, Yuan Qiu, Sondra Song Jie Chen, Angelica Rivas, Laura E. Banfield, Haifa Alfaraidi, Ahlam Alotaibi et al. · 2022 · JAMA Network Open
  59. Polycystic ovary syndrome and insulin resistance: Thrifty genes struggling with over-feeding and sedentary life style?
    Holte, Jan · 1998 · Journal of Endocrinological Investigation
  60. Selective alterations in insulin receptor substrates-1, -2 and -4 in theca but not granulosa cells from polycystic ovaries
    H-W. Yen · 2004 · Molecular Human Reproduction
  61. Polymorphism T → C (−34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study
    Bárbara Echiburú, Francisco Pérez‐Bravo, Manuel Alejandro Maliqueo, Fernando Sánchez, Nicolás Crisosto, Teresa Sir‐Petermann · 2008 · Metabolism
  62. Recombinant luteinizing hormone induces increased production of ovarian follicular adiponectin in vivo: implications for enhanced insulin sensitivity
    Guy Gutman, Vivian Barak, Sharon Maslovitz, Ami Amit, Joseph B. Lessing, Eli Geva · 2008 · Fertility and Sterility
  63. Evidence for pancreatic β-cell dysfunction in brothers of women with polycystic ovary syndrome
    Susan Sam, Yeon‐Ah Sung, Richard S. Legro, Andrea Elizabeth Dunaif · 2007 · Metabolism
  64. Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis
    Bülent Yılmaz, Priyathama Vellanki, Barış Ata, Bülent Okan Yıldız · 2018 · Fertility and Sterility
  65. Cardiometabolic aspects of polycystic ovarian syndrome.
    Li Wei Cho, Harpal Singh Randeva, Stephen Lawrence Atkin · 2007 · PubMed Central
  66. Pancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation
    Steven K. Malin, John P. Kirwan, Chang Ling Sia, Frank González · 2015 · American Journal of Physiology-Endocrinology and Metabolism
  67. Insulin resistance in clomiphene responders and non‐responders with polycystic ovarian disease and therapeutic effects of metformin
    Mohammad Ebrahim Parsanezhad, Saeed Alborzi, Afsoon Zarei, S Dehbashi, Gholamhossein Ranjbar Omrani · 2001 · International Journal of Gynecology & Obstetrics
  68. Metformin Improves Glucose Effectiveness, Not Insulin Sensitivity: Predicting Treatment Response in Women With Polycystic Ovary Syndrome in an Open-Label, Interventional Study
    Cindy Ta Pau, Candace C. Keefe, Jessica M. Duran, Corrine Kolka Welt · 2014 · The Journal of Clinical Endocrinology & Metabolism
  69. Beta-cell failure in the pathogenesis of type 2 diabetes mellitus
    Jeanne H. Steppel, Edward S. Horton · 2004 · Current Diabetes Reports
  70. Polycystic Ovary Syndrome and the Metabolic Syndrome
    Julie L. Sharpless · 2003 · Clinical Diabetes
  71. Genomic variants in polycystic ovary syndrome
    Manuel Luque‐Ramírez, José L. San Millán, Héctor Francisco Escobar-Morreale · 2005 · Clinica Chimica Acta
  72. Polycystic ovary syndrome: an endocrine and metabolic disease
    Antonietta Maria Scarpitta, Domenico Sinagra · 2000 · Gynecological Endocrinology
  73. INSULIN-LOWERING THERAPEUTIC MODALITIES FOR POLYCYSTIC OVARY SYNDROME
    David A. Ehrmann · 1999 · Endocrinology and Metabolism Clinics of North America
  74. Disruption of Growth Factor Receptor–Binding Protein 10 in the Pancreas Enhances β-Cell Proliferation and Protects Mice From Streptozotocin-Induced β-Cell Apoptosis
    Jingjing Zhang, Ning Zhang, Meilian Liu, Xiuling Li, Lijun Zhou, Wei Huang, Zhipeng Xu, Jing Liu, Nicolas Musi, Ralph Anthony DeFronzo et al. · 2012 · Diabetes
  75. Association of Parity With Risk of Type 2 Diabetes and Related Metabolic Disorders
    Anthony J. Hanley, Gail McKeown‐Eyssen, Stewart B. Harris, Robert Alexander Hegele, Thomas M. S. Wolever, Jeremy Kwan, Bernard Zinman · 2002 · Diabetes Care
  76. Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
    Gurkiran Dhindsa, Ruchi Bhatia, Mandeep Dhindsa, Vishal Bhatia · 2004 · PubMed
  77. Determinants of Impaired Fasting Glucose Versus Glucose Intolerance in Polycystic Ovary Syndrome
    Sidika E. Karakas, Kyoungmi Kim, Antoni J. Dulęba · 2010 · Diabetes Care
  78. Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome
    Katie Nitsche, David A. Ehrmann · 2010 · Best Practice & Research Clinical Endocrinology & Metabolism
  79. Adipocyte Insulin Resistance in PCOS: Relationship With GLUT-4 Expression and Whole-Body Glucose Disposal and β-Cell Function
    Uche I. Ezeh, Ida Yii-Der Chen, Yen‐Hao Chen, Ricardo Azziz · 2020 · The Journal of Clinical Endocrinology & Metabolism
  80. Adolescent Polycystic Ovary Syndrome Due to Functional Ovarian Hyperandrogenism Persists Into Adulthood
    Robert L. Rosenfield, David A. Ehrmann, Elizabeth Littlejohn · 2015 · The Journal of Clinical Endocrinology & Metabolism
  81. Polycystic Ovary Syndrome and Hyperandrogenic States
    R. Jeffrey Chang, Daniel Anthony Dumesic · 2019 · Elsevier eBooks
  82. Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women
    Elisabeth Lerchbaum, Verena Theiler‐Schwetz, Albrecht Giuliani, Barbara Maria Obermayer-Pietsch · 2014 · European Journal of Endocrinology
  83. Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance
    David A. Ehrmann, Elena Breda, Melissa K. Cavaghan, Sanija Bajramovic, Jacqueline Imperial, GIANNA MARIA TOFFOLO, Claudio Cobelli, Kenneth S. Polonsky · 2002 · Diabetologia
  84. Adverse pregnancy conditions, infertility, and future cardiovascular risk: implications for mother and child
    Park, Ki, Wei, Janet, Minissian, Margo, Bairey Merz, C. Noel, Pepine, Carl J. · 2015 · Cardiovascular Drugs and Therapy
  85. Continuation of Metformin Reduces Early Pregnancy Loss in Obese Pakistani Women with Polycystic Ovarian Syndrome
    Fauzia Haq Nawaz, Javed Rizvi · 2009 · Gynecologic and Obstetric Investigation
  86. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial
    Samira J Jafari-Sfidvajani, Roghaye Ahangari, Mohammad Hozoori, Hassan Mozaffari–Khosravi, Hossein Fallahzadeh, Azadeh Nadjarzadeh · 2017 · Journal of Endocrinological Investigation
  87. Polycystic ovary syndrome is associated with genetic polymorphism in the insulin signaling gene IRS-1 but not ENPP1 in a Japanese population
    Tsuyoshi Baba, Toshiaki Endo, Fumihiro Sata, Hiroyuki Honnma, Yoshimitsu Kitajima, Takuhiro Hayashi, Kengo Manase, Mika Kanaya, Hideto Yamada, Hisanori Minakami et al. · 2007 · Life Sciences
  88. Genetics of polycystic ovary syndrome
    Stephen Franks, Neda Gharani, Dawn M. Waterworth, Sari Batty, Davinia M. White, Robert Williamson, Mark I. McCarthy · 1998 · Molecular and Cellular Endocrinology
  89. Metformin before and during pregnancy and lactation in polycystic ovary syndrome
    Glueck, Charles J, Wang, Ping · 2007 · Expert Opinion on Drug Safety
  90. Second World Congress on the Insulin Resistance Syndrome
    Zachary T. Bloomgarden · 2005 · Diabetes Care
  91. Role of changes in dietary habits in polycystic ovary syndrome
    Renato Pasquali, Alessandra Gambineri · 2004 · Reproductive BioMedicine Online
  92. Insulin Dynamics in Young Women with Polycystic Ovary Syndrome and Normal Glucose Tolerance across Categories of Body Mass Index
    Melania Manco, Lidia Castagneto‐Gissey, Eugenio Arrighi, Annamaria Carnicelli, Claudia Brufani, Rosa Luciano, Geltrude Mingrone · 2014 · PLoS ONE
  93. Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications
    Ann E. Taylor · 1998 · American Journal of Obstetrics and Gynecology
  94. INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
    Ann E. Taylor · 2000 · Obstetrics and Gynecology Clinics of North America
  95. The Circadian Variation in Anti-Müllerian Hormone in Patients with Polycystic Ovary Syndrome Differs Significantly from Normally Ovulating Women
    Leif J. Bungum, Florencia Franssohn, Mona Bungum, Peter Humaidan, Aleksander Giwercman · 2013 · PLoS ONE
  96. Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences
    Kousta, Eleni, Tolis, George, Franks, Stephen · 2005 · HORMONES
  97. Insulin Resistance in the Polycystic Ovary Syndrome
    Andrea Elizabeth Dunaif, C. B. Book · 1997 · Humana Press eBooks
  98. Young women with polycystic ovary syndrome have raised levels of circulating annexin V-positive platelet microparticles
    Gareth R. Willis, Katherine D. Connolly, Kristin Ladell, T.S. Davies, Irina A. Guschina, Dipak P. Ramji, Kelly L. Miners, David A. Price, Aled Clayton, Philip Eurig James et al. · 2014 · Human Reproduction
  99. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome
    Bindu Kulshreshtha, Mohammed Ashraf Ganie, Edavan Pulikkanath Praveen, Nandita Gupta, Madan Lal Khurana, Ashu Seith, Sadanand N. Dwivedi, Guresh Kumar, Ariachery Chinnama Ammini · 2008 · Gynecological Endocrinology
  100. The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism
    Manuel Luque‐Ramírez, Macarena Alpañés, Héctor Francisco Escobar-Morreale · 2010 · Fertility and Sterility